BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Alopecia areata clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for alopecia areata: 83 (54 sponsors; 20 newly posted in the last 180 days, 6 stopped in the last 180 days; 11 new-entrant sponsors). Momentum score 24.1, rank 15 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 1, Phase 1 6, Phase 2 19, Phase 3 26, Phase 4 0, N/A 31.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Pfizer PFE8P3 4, NA 422
AbbVie ABBV4NA 1, P3 310
Veradermics, Inc. MANE4P3 3, P2 101
Applied Biology, Inc.3P3 2, P2 102
EMS2P3 201
Eurofarma Laboratorios S.A.2P3 200
Sun Pharmaceutical Industries, Inc.2P3 201
Eli Lilly and Company LLY2P2 1, P3 100
Industrial Farmacéutica Cantabria, S.A.2P3 1, NA 100
Pelage Pharmaceuticals, Inc. new entrant2P3 1, P2 120
Apsen Farmaceutica S.A.1P3 100
Chong Kun Dang Pharmaceutical1P3 100
Sun Pharma Japan Limited new entrant1P3 110
Suzhou Kintor Pharmaceutical Inc,1P3 100
Triple Hair Inc1P3 100
Restore Biologics Holdings, Inc. dba Xtressé6P2 1, NA 523
Jiangsu vcare pharmaceutical technology co., LTD new entrant2P1 1, P2 120
Olistic Research Labs S.L. new entrant2NA 222
Target PharmaSolutions, Inc. TGT2NA 210
Absci Pty Ltd. ABSI1P2 100
Acorn Biolabs Inc.1NA 100
Activ'inside new entrant1NA 111
Aldena Therapeutics1P2 100
Almirall, S.A.1P2 100
Bionos Biotech S.L.1NA 100

New-entrant sponsors: Pelage Pharmaceuticals, Inc., Sun Pharma Japan Limited, Jiangsu vcare pharmaceutical technology co., LTD, Olistic Research Labs S.L., Activ'inside.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P3Veradermics, Inc. MANENCT06972264 Safety and Efficacy of VDPHL01 in Males With AGAAndrogenetic Alopecia; AGA; Male Pattern Baldnessactive not recruiting480
2026-12-02 est.P3Pfizer PFENCT07029711 A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataSevere Alopecia Areataactive not recruiting208
2027-02-05 est.P1/P2Applied Biology, Inc.NCT07397325 Clinical Study of DA-020 for the Treatment of Chemotherapy Induced AlopeciaChemotherapy Induced Alopecia; Chemotherapy Side Effectsrecruiting60

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11 est.P1/P2Aldena TherapeuticsNCT06826196 A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia AreataAlopecia Areata (AA)active not recruiting9
2026-10-31 est.P2NEXTGEN BioscienceNCT06104839 Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia AreataAlopecia Areatarecruiting73
2026-10 est.P3Industrial Farmacéutica Cantabria, S.A.NCT05888922 Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic AlopeciaAndrogenetic Alopecia; Female Pattern Baldnessactive not recruiting520
2026-09 est.P1/P2Moogene Medi Co., LtdNCT07490327 Assessment of Dutasteride Topical Solution in Male Androgenetic AlopeciaAndrogenetic Alopecianot yet recruiting30
2026-08 est.P2Veradermics, Inc. MANENCT06527365 Safety and Efficacy of VDPHL01 in Males and Females With AGAAndrogenetic Alopecia; AGA; Male Pattern Baldnessactive not recruiting70
2026-06-30 est.P1/P2PT. Prodia Stem Cell IndonesiaNCT07429253 Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia PatientsAndrogenetic Alopeciarecruiting40
2026-06-06P3Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.NCT07080931 Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic AlopeciaAndrogenetic Alopeciacompleted296
2026-06 est.P2Q32 Bio Inc. QTTBNCT06018428 A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Alopecia Areataactive not recruiting75

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "alopecia areata"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.